Gel Implants Market

How big is the gel implants market in 2026?

USD 1.4 billion in 2026, reaching USD 1.9 billion by 2036 at a 3.3% CAGR

Key Takeaways, Market Size, and Forecast

• Gel Implants Market Value (2025): USD 1.3 Bn
• Gel Implants Market Forecast Value (2036): USD 1.9 Bn
• Gel Implants Market CAGR (2026 TO 2036): 3.3%
• Gel Implants Market Leading Product Segment: Breast Gel Implants (55.0%)
• Gel Implants Market Key Growth Regions: South Korea, USA, Japan, EU, UK
• Gel Implants Market Key Players: Allergan Aesthetics (AbbVie Inc.), Mentor Worldwide LLC (Johnson & Johnson), Sientra, Inc., GC Aesthetics, POLYTECH Health & Aesthetics GmbH

The gel implants market was valued at USD 1.3 billion in 2025. The market is set to reach USD 1.4 billion by 2026-end and grow at a CAGR of 3.3% between 2026-2036 to reach USD 1.9 billion by 2036. Breast Gel Implants will dominate with a 55.0% share, while Silicone Gel will lead with a 65.0% share.

Parameter	Details
Market Size in 2026 (Value)	USD 1.4 Bn
Market Forecast in 2036 (Value)	USD 1.9 Bn
CAGR (2026 to 2036)	3.3%
Years Considered	2021 to 2036
Base Year	2025
Forecast Period	2026 to 2036
Units Considered	Value (USD Bn)
Leading Sub-Region	USA

Summary of the Gel Implants Market

• Demand and Growth Drivers
  • Sustained demand for breast augmentation and reconstruction procedures maintains baseline procurement of silicone gel implants across aesthetic and medical indications.
  • Growing acceptance of breast augmentation across demographics and geographies is expanding the addressable patient population beyond traditional core markets.
  • Advancement in cohesive gel technology and implant shell design is improving safety profiles and reducing complication rates, supporting physician and patient confidence.
• Product and Segment View
  • Breast gel implants account for 55.0% of product share, reflecting the dominant role of breast augmentation and reconstruction in gel implant procedure volumes.
  • Silicone gel materials hold 65.0% of material share, as fifth and sixth-generation cohesive silicone gel provides the most natural aesthetic result and established safety profile.
  • Round implants hold 60.0% of shape share, preferred for breast augmentation where symmetric fullness and straightforward surgical positioning are valued.
• Geography and Competitive Outlook
  • South Korea leads at 3.6% CAGR, reflecting strong medical tourism for aesthetic procedures, established plastic surgery infrastructure, and high per-capita cosmetic surgery rates.
  • The United States follows at 3.5% CAGR, supported by the largest aesthetic surgery market, FDA-approved implant availability, and established plastic surgeon distribution networks.
  • Companies with FDA and CE approved cohesive gel implant portfolios and established plastic surgeon relationships are positioned for sustained demand.
• Analyst Opinion
  • Anurag Sharma, Principal Consultant at FMI says, 'Implant manufacturers that can deliver improved cohesive gel fill technology with reduced complication rates and long-term safety data are likely to strengthen surgeon preference and market positioning over the forecast period.'
  • The gel implants market is sustained by consistent global demand for breast augmentation and reconstruction procedures.
  • Adoption is increasing as improved implant technology and safety data provide greater physician and patient confidence in gel-filled devices.
  • Demand is supported by medical tourism growth, particularly in South Korea, Thailand, and Brazil, which creates concentrated procedure volumes at lower price points.
  • Growth is attributable to expanding indications including post-mastectomy reconstruction where insurance coverage supports implant procurement.

What are gel implants and what does the market cover?

Silicone-gel, hydrogel and hybrid-filled implant devices for breast augmentation, reconstruction and facial aesthetics

The gel implants market encompasses medical devices consisting of outer shells filled with silicone gel, hydrogel, or hybrid materials used in breast augmentation, breast reconstruction, facial augmentation, and other aesthetic and medical procedures. Products include breast gel implants, hydrogel implants, and facial gel implants in round and anatomical shapes manufactured using conventional, advanced cohesive gel, and bioengineered technologies.

What is included in the gel implants market scope?

Breast gel implants, hydrogel implants and facial gel implants in round and anatomical shapes, 2026 to 2036.

Market scope covers all commercially available gel implant products categorized by product (breast gel implants, hydrogel implants, facial gel implants), material (silicone gel, hydrogel materials, hybrid materials), shape (round implants, anatomical implants), application (aesthetic surgery, reconstructive surgery, medical and therapeutic), end use (hospitals, specialty clinics, ambulatory surgical centers), technology (conventional gel implants, advanced cohesive gel technology, smart and bioengineered implants), and procedure type (surgical implants, non surgical implants). Revenue is tracked from 2026 to 2036.

What is excluded from the gel implants market scope?

Saline-filled breast implants, tissue expanders, injectable dermal fillers, and non-implantable aesthetic devices

The scope does not include saline-filled breast implants, tissue expanders, injectable dermal fillers, or non-implantable aesthetic devices.

How was the gel implants market research conducted?

Primary interviews, desk research, bottom-up sizing, and quarterly validation

• Primary Research: FMI analysts conducted interviews with plastic surgeons, aesthetic clinic operators, implant manufacturers, and regulatory specialists across key markets.
• Desk Research: Collect data from databases on aesthetic surgery procedures, regulatory filings for medical devices, and revenue disclosures by manufacturers.
• Market Sizing and Forecasting Bottom-up aggregation of implant unit sales by product types, procedure indications and geographic markets with procedure volume forecasts.
• Data Validation: Cross validated quarterly with plastic surgery society procedure statistics, hospital implant procurement data and manufacturer shipment records.

Why is the gel implants market growing?

Rising breast augmentation volumes and broadening insurance coverage and clinical acceptance

• Demand for silicone gel implants continues to be consistent in terms of breast augmentation procedure volumes and globally, acceptance is expanding the addressable patient population.
• With insurance coverage and clinical pathways increasingly supporting implant-based reconstruction alongside tissue-based approaches, gel implants for post-mastectomy breast reconstruction are becoming more common.
• South Korea is the first with 3.6% CAGR as the country has the highest per-capita aesthetic surgery rate in the world with a well-established medical tourism structure for cosmetic treatments.

The demand for gel implants is driven by the global volume of breast augmentation procedures and the increasing use of implant-based breast reconstruction following mastectomy. Breast gel implants accounted for 55.0% of product share, and breast augmentation is the largest aesthetic surgery procedure globally, based on implant device volume. Silicone gel materials represent 65.0% of material share, with fifth and sixth generation cohesive gel formulations providing a natural feel and lower risk of gel migration than earlier silicone gel generations.

Round implants make up 60.0% of the shape share and are the preferred choice for breast augmentation, as the symmetric fullness and simplified surgical positioning reduce operative complexity. Anatomical (teardrop) implants meet the needs of patients and surgeons who desire a more natural breast contour, but concerns about implant rotation have limited adoption in some markets. The implant keeps its shape even if the shell is broken, due to the advanced cohesive gel technology with form-stable silicone.

Its primary application is in aesthetic surgery, with breast augmentation representing the largest segment in terms of number of procedures. One growing use case is reconstructive surgery after breast cancer treatment. Insurance or national health care coverage helps cover the cost of implants. Medical tourism, in particular South Korea, Thailand and Brazil, leads to a concentration of procedure volumes where international patients are attracted by lower total costs.

How is the gel implants market segmented?

By product, material, shape, application, end use, technology and procedure type

• Breast gel implants lead the product share at 55.0% and are used in the leading breast augmentation and reconstruction procedure types.
• Material share is 65.0% by silicone gel, with advanced cohesive formulations providing the established aesthetic and safety performance benchmark.
• Round implants hold 60% of shape share, popular for augmentation where symmetric fullness is desired and easy surgical placement.

Why do breast gel implants lead the gel implants market?

They hold 55.0% share, led by cohesive-gel silicone-shell devices

Breast gel implants account for 55.0% market share in 2026. They are made up of a silicone elastomer outer shell filled with cohesive silicone gel in a variety of projections and volumes. Implants range in size from approximately 100 cc to 800 cc. Most augmentation procedures use implants in the 250 cc to 450 cc range.

The latest generation of breast implants have a highly cohesive gel fill which helps maintain shape integrity and reduces the risk of gel migration. Surface options include smooth and textured shells, but some markets have applied regulatory scrutiny to textured implants and preference has shifted toward smooth surface devices.

How big is the silicone gel segment in the gel implants market?

About 65.0% share, led by cohesive silicone gel that mimics natural tissue

Silicone gel material 65.0% share in 2026. Of the implant fill materials available, medical-grade silicone gel most closely mimics natural tissue. Cohesive gel formulations vary from soft (responsive) to firm (form-stable), with surgeons choosing the degree of cohesivity based on patient anatomy, desired aesthetic outcome and surgical approach.

In some applications where silicone is not the desired fill, hydrogel materials are an option. Hybrid materials that combine silicone and other biocompatible materials are being developed to achieve improved safety and performance profiles.

What drives and restrains the gel implants market?

Driven by breast augmentation and reconstruction demand; restrained by regulatory scrutiny of implant safety

• Breast augmentation procedure demand and growing reconstruction indications sustain baseline gel implant procurement globally.
• Regulatory scrutiny of implant safety, particularly textured surface concerns, creates periodic market disruption and product availability changes.
• Growth opportunity in the development of advanced cohesive gels and bioengineered implants for improved safety and aesthetic outcomes.

Moderate growth in the gel implants market is driven by aesthetic demand, reconstruction indications and technology advancement. The regulatory scrutiny creates market uncertainty and improved safety technology and increasing global procedure access creates growth pathways.

What drives demand?

Sustained global interest in breast augmentation as a staple procedure

The demand is fueled by sustained global interest in breast augmentation as a staple aesthetic procedure. Social acceptance and expanding demographics increase patient population in both developed and emerging aesthetic surgery markets.

What constrains the market?

Scrutiny of textured surfaces and implant-associated safety concerns

Concerns regarding textured surfaces and implant safety, including breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), influence adoption. Some markets have regulatory actions that have restricted availability of textured implants, which has caused demand to move toward smooth surface options.

What opportunity does reconstruction offer?

Rising insurance coverage for post-mastectomy breast reconstruction

The growth is driven by increasing insurance and healthcare coverage for post-mastectomy breast reconstruction with gel implants. The use of clinical pathways incorporating implant-based reconstruction in breast cancer treatment plans increases the proportion of mastectomy patients receiving reconstructive implants.

Where is demand concentrated?

Medical tourism in South Korea, Thailand and Brazil offering lower-cost procedures

Demand is concentrated by medical tourism in South Korea, Thailand, and Brazil where lower procedure costs attract international patients for breast augmentation. These medical tourism hubs create concentrated implant procurement at specialized aesthetic surgery clinics.

Which countries are growing fastest in the gel implants market?

South Korea 3.6%, USA 3.5%, Japan 3.4%, EU 3.3%, UK 3.1% through 2036

Country	CAGR
USA	3.5%
UK	3.1%
EU	3.3%
Japan	3.4%
South Korea	3.6%

• South Korea leads at 3.6% CAGR, indicating strong demand drivers.
• USA 3.5% and rising market activity.
• Japan (3.4%) and the EU (3.3%) continue the growth.

The global gel implants market is estimated to grow at 3.3% CAGR from 2026 to 2036. The study covers more than 30 countries, and the key markets are listed below.

How fast is the gel implants market growing in South Korea?

3.6% CAGR through 2036, the fastest country-level market in the study

South Korea leads at 3.6% CAGR through 2036. The highest per-capita aesthetic surgery rate globally and established medical tourism infrastructure sustain market leadership.

• Gangnam district plastic surgery clinics operate at high procedure volumes, creating concentrated gel implant procurement demand.
• Medical tourism from China, Japan, and Southeast Asia creates additional procedure volumes beyond domestic demand.
• Korean implant regulatory standards and MFDS oversight ensure device quality and safety compliance.

What is the gel implants market outlook in the United States?

3.5% CAGR, driven by the largest aesthetic surgery market, an FDA-approved implant portfolio, and established plastic surgeon distribution

The United States is projected to register 3.5% CAGR through 2036. Demand is backed by the largest aesthetic surgery market, FDA-approved implant portfolio and established plastic surgeon distribution.

• Plastic surgeons in the US use the approved product portfolio from FDA-approved implant manufacturers Allergan, Mentor and Sientra.
• Breast augmentation is still the most popular cosmetic surgery in the United States, with a steady number of gel implant purchases.
• Insurance-covered post-mastectomy breast reconstruction increases the demand for medical indications in parallel to aesthetic procedures.

What is driving gel implants growth in Japan?

3.4% CAGR, driven by Established aesthetic surgery industry and quality-focused consumer culture

Japan is projected to register 3.4% CAGR through 2036. Established aesthetic surgery industry and quality-focused consumer culture sustain demand.

• Japanese aesthetic surgery market sustains gel implant demand through established plastic surgery clinics in Tokyo, Osaka, and other major cities.
• Quality-conscious Japanese consumers demand high-specification implant products with documented safety and performance.
• PMDA regulatory approval ensures device quality standards for implants marketed in the Japanese aesthetic surgery market.

How is the gel implants market performing in the European Union?

3.3% CAGR, driven by CE marked implant availability and established aesthetic surgery markets

The European Union is projected to register 3.3% CAGR through 2036. CE marked implant availability and established aesthetic surgery markets sustain demand.

• EU MDR compliance requirements ensure implant quality and safety documentation for products marketed across member states.
• Aesthetic surgery markets in France, Germany, Italy, and Spain sustain gel implant procedure volumes across augmentation and reconstruction indications.
• Regulatory actions on textured implants in France have influenced implant surface selection patterns across EU markets.

What is the gel implants market forecast for the United Kingdom?

3.1% CAGR, driven by Established aesthetic surgery and NHS reconstruction services

The United Kingdom is projected to register 3.1% CAGR through 2036. Established aesthetic surgery and NHS reconstruction services sustain demand.

• Private aesthetic surgery clinics across the UK sustain breast augmentation procedure volumes that drive gel implant procurement.
• NHS breast reconstruction services provide implant-based reconstruction for mastectomy patients under national health service coverage.
• CQC regulation of cosmetic surgery providers ensures clinical standards for implant procedures performed in UK facilities.

Who are the leading companies in the gel implants market?

Allergan Aesthetics (AbbVie Inc.), Mentor Worldwide LLC (Johnson & Johnson), Sientra, Inc., GC Aesthetics, and POLYTECH Health & Aesthetics GmbH

• Allergan Aesthetics (AbbVie) leads through the Natrelle implant portfolio with the broadest range of gel-filled breast implant options and established plastic surgeon loyalty.
• Mentor Worldwide (Johnson and Johnson) competes through the MemoryGel and MemoryShape product lines with strong US and international market presence.
• Sientra provides a differentiated position as the only US manufacturer selling exclusively to board-certified plastic surgeons.
• GC Aesthetics and POLYTECH serve European and international markets through CE-marked gel implant portfolios with established distribution.

Who are the key players in the gel implants market?

Allergan Aesthetics (AbbVie Inc.), Mentor Worldwide LLC (Johnson & Johnson), Sientra, Inc., GC Aesthetics and POLYTECH Health & Aesthetics GmbH, plus regional players

Key global companies leading the gel implants market include:

• Allergan Aesthetics/AbbVie Inc. (USA), Mentor Worldwide LLC/Johnson and Johnson (USA), Sientra, Inc. (USA), and GC Aesthetics (Ireland) lead global gel implant markets through comprehensive product portfolios, regulatory approvals across major markets, and established plastic surgeon distribution networks.
• POLYTECH Health and Aesthetics GmbH (Germany) holds a strong European position through German-manufactured gel implant products with CE marking and established plastic surgeon distribution.
• Additional implant manufacturers are developing next-generation cohesive gel and bioengineered implant technologies targeting improved safety profiles and expanded clinical applications.

How do top gel implants companies compare?

Allergan Aesthetics (AbbVie Inc.) and Mentor Worldwide LLC (Johnson & Johnson) lead globally; Sientra, Inc., GC Aesthetics and POLYTECH Health & Aesthetics GmbH are regional specialists

Company	Implant Portfolio	Surgeon Relationships	Regulatory Approvals	Geographic Footprint
Allergan (AbbVie)	High	High	Strong	Global
Mentor (J&J)	High	High	Strong	Global
Sientra	Medium	Medium	Moderate	N. America
GC Aesthetics	Medium	Medium	Moderate	Europe, Global
POLYTECH	Medium	Medium	Moderate	Europe

Source: Future Market Insights competitive analysis, 2026.

Key Developments in Gel Implants Market

• In 2025, Allergan Aesthetics continued expanding awareness and adoption of its Natrelle® breast implant portfolio, which includes multiple cohesive-gel implant options for breast augmentation and reconstruction procedures, supported by ongoing clinical evidence and patient engagement initiatives.
• In 2025, leading gel implant manufacturers continued focusing on breast reconstruction and aesthetic surgery applications through broader portfolios of cohesive silicone-gel implants, offering surgeons a wider range of profile, shape, and gel-consistency options to support individualized patient outcomes.

Key Players in the Gel Implants Market

Major Global Players

• Allergan Aesthetics (AbbVie Inc.)
• Mentor Worldwide LLC (Johnson & Johnson)
• Sientra, Inc.
• GC Aesthetics
• POLYTECH Health & Aesthetics GmbH

Emerging Players/Startups

• Establishment Labs Holdings Inc.
• HansBiomed Co., Ltd.
• Sebbin

Gel Implants Market - Research Methodology

Method	Description
Primary Research	FMI analysts conducted interviews with manufacturers, distributors, procurement specialists, and end-use operators across USA, UK, and EU to validate demand patterns and pricing structures for Breast Gel Implants, and Hydrogel Implants and related product categories.
Desk Research	Combined trade statistics, regulatory filings, industry association data, and manufacturer disclosures to establish baseline parameters for Gel Implants across product, material, shape, application, end use, technology, and procedure segments.
Market Sizing & Forecasting	Bottom-up aggregation across Breast Gel Implants, Hydrogel Implants, and Facial Gel Implants product categories and Silicone Gel, Hydrogel Materials, and Hybrid Materials material segments, triangulated with top-down macro indicators and regional adoption curves.
Data Validation	Cross-checked quarterly against production statistics, trade flow data, and manufacturer revenue disclosures for Gel Implants products.

What does the gel implants market report cover?

2016 to 2025 history and 2026 to 2036 forecasts across all segments and 30+ countries

Parameter	Details
Market size by 2036	USD 1.9 Bn
Growth rate	3.3% CAGR (2026 to 2036)
Forecast period	2026 to 2036
Base year value (2025)	USD 1.3 Bn
Key Segment Covered	Product, Material, Shape, Application, End Use, Technology, Procedure Type
Regions covered	North America, Latin America, Eastern Europe, Western Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries covered	USA, UK, EU, Japan, South Korea, 30 plus countries
Key companies profiled	Allergan Aesthetics (AbbVie Inc.), Mentor Worldwide LLC (Johnson & Johnson), Sientra, Inc., GC Aesthetics, POLYTECH Health & Aesthetics GmbH
Approach	Hybrid bottom-up and top-down methodology starting with verified transaction data, projecting adoption velocity across segments and regions.

Market Segmentation Analysis

Gel Implants Market Segmented by Product:

• Breast Gel Implants
  • Silicone Gel Breast Implants
    • Round Implants
    • Anatomical Implants
  • Cohesive Gel Breast Implants
    • Form Stable Implants
    • Highly Cohesive Implants
• Hydrogel Implants
  • Hyaluronic Acid Based Implants
    • Soft Tissue Fillers
    • Temporary Implants
  • Polymer Based Hydrogel Implants
    • Biocompatible Gels
    • Absorbable Implants
• Facial Gel Implants
  • Dermal Fillers
    • Lip Enhancement
    • Cheek Augmentation
  • Facial Contouring Implants
    • Jawline Enhancement
    • Chin Augmentation
• Orthopedic Gel Implants
  • Cartilage Replacement Implants
    • Joint Repair
    • Soft Tissue Support
  • Spinal Gel Implants
    • Disc Replacement
    • Cushioning Systems

Gel Implants Market Segmented by Material:

• Silicone Gel
  • Standard Silicone Gel
    • Soft Gel
    • Medium Cohesivity
  • Highly Cohesive Silicone Gel
    • Form Stable Gel
    • Shape Retaining Gel
• Hydrogel Materials
  • Natural Hydrogels
    • Hyaluronic Acid
    • Collagen Based
  • Synthetic Hydrogels
    • Polyacrylamide
    • Polymer Blends
• Hybrid Materials
  • Silicone Hydrogel
    • Enhanced Flexibility
    • Improved Biocompatibility
  • Composite Materials
    • Multi Layer Structures
    • Advanced Performance

Gel Implants Market Segmented by Shape:

• Round Implants
  • Low Profile
    • Natural Contour
    • Subtle Enhancement
  • High Profile
    • Full Projection
    • Enhanced Volume
• Anatomical Implants
  • Tear Drop Shape
    • Natural Look
    • Gradual Slope
  • Custom Shaped Implants
    • Patient Specific Design
    • 3D Modeled Implants

Gel Implants Market Segmented by Application:

• Aesthetic Surgery
  • Breast Augmentation
    • Cosmetic Enhancement
    • Volume Restoration
  • Facial Aesthetics
    • Wrinkle Reduction
    • Facial Contouring
• Reconstructive Surgery
  • Post Mastectomy Reconstruction
    • Breast Reconstruction
    • Symmetry Correction
  • Trauma Reconstruction
    • Soft Tissue Repair
    • Defect Correction
• Medical and Therapeutic
  • Orthopedic Applications
    • Joint Repair
    • Spinal Treatment
  • Dermatology
    • Scar Treatment
    • Skin Regeneration

Gel Implants Market Segmented by End Use:

• Hospitals
  • Private Hospitals
    • Cosmetic Surgery Units
    • Reconstructive Surgery
  • Public Hospitals
    • Oncology Departments
    • General Surgery
• Specialty Clinics
  • Cosmetic Clinics
    • Aesthetic Procedures
    • Outpatient Surgeries
  • Dermatology Clinics
    • Non Surgical Procedures
    • Injectable Treatments
• Ambulatory Surgical Centers
  • Day Care Centers
    • Minimally Invasive Procedures
    • Quick Recovery Surgeries
• Medical Spas
  • Aesthetic Centers
    • Non Surgical Enhancements
    • Beauty Treatments

Gel Implants Market Segmented by Technology:

• Conventional Gel Implants
  • Standard Silicone Implants
    • Basic Cohesivity
    • Traditional Designs
• Advanced Cohesive Gel Technology
  • Gummy Bear Implants
    • High Shape Retention
    • Reduced Leakage Risk
  • Progressive Gel Technology
    • Variable Cohesivity
    • Natural Feel
• Smart and Bioengineered Implants
  • Biocompatible Coatings
    • Reduced Rejection Risk
    • Enhanced Integration
  • 3D Customized Implants
    • Patient Specific Design
    • Precision Surgery

Gel Implants Market Segmented by Procedure Type:

• Surgical Implants
  • Open Surgical Procedures
    • Breast Augmentation Surgery
    • Reconstructive Surgery
  • Minimally Invasive Surgery
    • Small Incision Procedures
    • Reduced Recovery Time
• Non Surgical Implants
  • Injectable Gel Implants
    • Dermal Fillers
    • Temporary Enhancements
  • Regenerative Treatments
    • Bioactive Gel Systems
    • Tissue Regeneration

Gel Implants Market by Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Türkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Research Sources and Bibliography

• USA Food and Drug Administration. (2025). FDA Regulatory Framework for Breast Implant Devices. FDA.
• European Commission. (2025). EU Medical Device Regulation: Implantable Device Requirements. EC.
• American Society of Plastic Surgeons. (2025). ASPS Plastic Surgery Statistics Report. ASPS.
• International Society of Aesthetic Plastic Surgery. (2025). ISAPS Global Survey of Aesthetic Procedures. ISAPS.
• World Health Organization. (2025). WHO Global Report on Medical Devices Safety. WHO.

This bibliography is provided for reader reference.

This Report Answers

• Estimating the size of the gel implants market and projected revenue from 2026 to 2036.
• Segmentation by product, material, shape, application, end use, technology, procedure type.
• Insights about more than 30 regional markets.
• Analysis of key market dynamics including demand drivers, restraints, and emerging opportunities.
• Assessment of the competitive landscape and strategic positioning of leading companies.
• Identifying investment opportunities across key product segments and geographic markets.
• Supply chain and distribution channel analysis.
• Delivery of data in PDF and Excel formats.